Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism - PubMed (original) (raw)

Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism

G E Rice et al. J Exp Med. 1990.

Abstract

Inducible cell adhesion molecule 110 (INCAM-110) is a 110-kD glycoprotein expressed on cytokine-activated human vascular endothelial cells. mAb blocking studies indicate that INCAM-110 and intercellular adhesion molecule 1 (ICAM-1) independently support the adhesion of lymphocytes to activated human umbilical vein endothelial cell monolayers. Anti-CD11a/CD18 antibodies with anti-INCAM-110 mAb E1/6 produce greater inhibition of lymphocyte adhesion than either reagent alone, suggesting that INCAM-110 and LFA-1 are not an obligate receptor-ligand pair. Blood monocytes, but not polymorphonuclear leukocytes, also appear to bind endothelial INCAM-110. Endothelial expression of INCAM-110 is upregulated at sites of inflammation, suggesting a role in the recruitment of mononuclear leukocytes.

PubMed Disclaimer

Similar articles

• Monocyte attachment to activated human vascular endothelium in vitro is mediated by leukocyte adhesion molecule-1 (L-selectin) under nonstatic conditions.
  Spertini O, Luscinskas FW, Gimbrone MA Jr, Tedder TF. Spertini O, et al. J Exp Med. 1992 Jun 1;175(6):1789-92. doi: 10.1084/jem.175.6.1789. J Exp Med. 1992. PMID: 1375271 Free PMC article.
• Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology.
  Patarroyo M, Prieto J, Rincon J, Timonen T, Lundberg C, Lindbom L, Asjö B, Gahmberg CG. Patarroyo M, et al. Immunol Rev. 1990 Apr;114:67-108. doi: 10.1111/j.1600-065x.1990.tb00562.x. Immunol Rev. 1990. PMID: 1973408 Review.
• The acute inflammatory reaction.
  Ward PA, Marks RM. Ward PA, et al. Curr Opin Immunol. 1989 Oct;2(1):5-9. doi: 10.1016/0952-7915(89)90090-3. Curr Opin Immunol. 1989. PMID: 2482043 Review.

Cited by

• Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.
  Gimbrone MA Jr, García-Cardeña G. Gimbrone MA Jr, et al. Circ Res. 2016 Feb 19;118(4):620-36. doi: 10.1161/CIRCRESAHA.115.306301. Circ Res. 2016. PMID: 26892962 Free PMC article. Review.
• Macrophages: Key regulators of steady-state and demand-adapted hematopoiesis.
  McCabe A, MacNamara KC. McCabe A, et al. Exp Hematol. 2016 Apr;44(4):213-22. doi: 10.1016/j.exphem.2016.01.003. Epub 2016 Jan 22. Exp Hematol. 2016. PMID: 26806720 Free PMC article. Review.
• Transgene expression study of CXCR4 active mutants. Potential prospects in up-modulation of homing and engraftment efficiency of hematopoietic stem/progenitor cells.
  Sharma M, Afrin F, Tripathi RP, Gangenahalli G. Sharma M, et al. Cell Adh Migr. 2014;8(4):384-8. doi: 10.4161/cam.29285. Cell Adh Migr. 2014. PMID: 25482641 Free PMC article.
• Leukocyte traffic blockade as a therapeutic strategy in inflammatory bowel disease.
  Bamias G, Clark DJ, Rivera-Nieves J. Bamias G, et al. Curr Drug Targets. 2013 Nov;14(12):1490-500. doi: 10.2174/13894501113149990158. Curr Drug Targets. 2013. PMID: 23621509 Free PMC article. Review.
• Phenotypic and functional changes in blood monocytes following adherence to endothelium.
  Tso C, Rye KA, Barter P. Tso C, et al. PLoS One. 2012;7(5):e37091. doi: 10.1371/journal.pone.0037091. Epub 2012 May 15. PLoS One. 2012. PMID: 22615904 Free PMC article.

References

1. 1. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9238-42 - PubMed
2. 1. J Cell Biol. 1988 Jul;107(1):321-31 - PubMed
3. 1. J Immunol. 1986 Jul 1;137(1):245-54 - PubMed
4. 1. J Immunol. 1986 Sep 15;137(6):1893-6 - PubMed
5. 1. J Cell Physiol. 1988 Nov;137(2):305-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations

• Miscellaneous

  • NCI CPTAC Assay Portal